Combination therapies for the treatment of HER2-positive breast cancer: current and future prospects
par Brandao, Marianna;Pondé, Noam;Poggio, Francesca;Kotecki, Nuria;Salis, Mauren;Lambertini, Matteo 
;de Azambuja, Evandro
Référence Expert review of anticancer therapy, 18, 7, page (629-649)
Publication Publié, 2018-07
;de Azambuja, Evandro Référence Expert review of anticancer therapy, 18, 7, page (629-649)
Publication Publié, 2018-07
Article révisé par les pairs
| Titre: |
|
| Auteur: | Brandao, Marianna; Pondé, Noam; Poggio, Francesca; Kotecki, Nuria; Salis, Mauren; Lambertini, Matteo; de Azambuja, Evandro |
| Informations sur la publication: | Expert review of anticancer therapy, 18, 7, page (629-649) |
| Statut de publication: | Publié, 2018-07 |
| Sujet CREF: | Pharmacologie |
| Cancérologie | |
| Mots-clés: | Breast neoplasms |
| cost-benefit analysis | |
| HER2-positive | |
| quality of life | |
| trastuzumab | |
| Note générale: | SCOPUS: re.j |
| Langue: | Anglais |
| Identificateurs: | urn:issn:1473-7140 |
| info:doi/10.1080/14737140.2018.1477596 | |
| info:scp/85048816910 |
